NASDAQ · Financial Statements
Fennec Pharmaceuticals Inc. (FENC) Financial Statements
$10.76
NASDAQ: FENC
Market Cap $373.77M
Overview Financials Dividend Fennec Pharmaceuticals Inc. most recently reported annual revenue of $45.0M, net profit of $-10.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $2.0M $21.0M $48.0M $45.0M Operating Profit $-17.0M $-23.0M $-13.0M $2.0M $-6.0M Net Profit $-17.0M $-24.0M $-16.0M $0 $-10.0M EPS $-0.67 $-0.95 $-0.60 $-0.02 $-0.36 Op Margin — -1481.3% -61.4% 5.2% -14.2%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $22.0M $27.0M $27.0M $45.0M $70.0M Total Liabilities $7.0M $30.0M $38.0M $51.0M $35.0M Cash $21.0M $24.0M $13.0M $27.0M $37.0M Borrowings $5.0M $25.0M $31.0M $19.0M $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-14.0M $-18.0M $-17.0M $27.0M $-12.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $1.0M $2.0M $-1.0M $-3.0M Net Cash Flow $-9.0M $3.0M $-11.0M $13.0M $10.0M Free Cash Flow $-14.0M $-18.0M $-17.0M $27.0M $-12.0M
Valuation & Return Ratios
Metric Value PEG Ratio -1.40 EV / EBITDA -131.76 FCF Yield -0.58% Quick Ratio 5.66 Interest Coverage -1.29 Return 1Y 16.27% Return 3Y 25.00% Return 5Y 68.84%
Screens featuring this stock